Our panel of AML cell lines covered the majority of the morphologic and molecular subtypes, particularly including FLT3-ITD and FLT3 wild type, NPM1 mutant and wild type, as well as TP53 wild type, mutant, hemizygous, and null cells (Table 1). This evidence concerns the gene FLT3 and acute myeloid leukemia.